- Our World
- Our Business
- Life at Lupin
- Global Sites
Lupin's global manufacturing operations are spread across India and Japan. The Company has 12 world-class facilities (ten in India and two in Japan) manufacturing and supplying APIs and formulations approved by leading pharmaceutical regulatory authorities like the US FDA, World Health Organisation, MHRA (UK), TGA (Australia), MHLW (Japan), ANVISA (Brazil) and MCC (South Africa). These world-class facilities embody a culture of continuous improvement to deliver complex products with optimum efficiency. With a focus on maintaining the right efficiencies, Lupin has continued on its quest for anufacturing excellence, focusing on cost reduction using principles of six sigma and lean manufacturing.
We believe Quality and Regulatory Compliance not only have to be embedded into the product but have to be built into people, systems, and processes through a systematic process of continuous training and knowledge sharing. The Company today has over 700 Global Corporate Quality Assurance professionals spread across all manufacturing locations engaged in developing and implementing policies that ensure quality and compliance with global regulatory standards. Consistency in meeting customer expectations and meeting regulatory quality and compliance norms are the true enablers and the critical differentiator that has made Lupin the global generic powerhouse it is today.
As we aspire to further accelerate and scale higher orbits of growth, we are conscious of the fact that product and market complexity will increase exponentially. We are aware that the Company needs to stay ahead of the curve by continuously investing in new technology, automation and systems to create better efficiencies that enhance profitability. We are also investing prudently in expanding our manufacturing operations by setting up new facilities and plants to meet future demand. As a result, the Company's capital expenditure increased to Rs. 4,871 million for FY 2013. We actively engage with leading consulting organisations to build a manufacturing operation second to none and continuously sharpen our compliance ethic. As we aspire to further accelerate our growth and in order to ensure that we consistently meet our customer expectations, we have realised that we must invest in building a future-ready, nimble and strong supply chain. With that objective in mind, the Company launched its Supply Chain Operations Re-Engineering (SCORE) program covering its manufacturing facilities, supply chain and all markets during FY 2013.